Nerviano Medical Sciences and Italfarmaco Announce Licensing of Linker-Payload Technology to Develop and Commercialize a Novel Peptide-Drug Conjugate
NERVIANO, Italy & MILAN--(BUSINESS WIRE)--Dec 14, 2023--
Source: valdostadailytimes.com
Solve Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Solve Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Solve Therapeutics Today - Breaking & Trending Today
Cancer Therapy Company Acquires Durham-Based Cereius | North Carolina Biotechnology Center
Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).
Source: ncbiotech.org
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out
/PRNewswire/ -- Solve Therapeutics, Inc. (SolveTx), a biopharmaceutical company developing novel antibody-based therapeutics, announces the acquisition of...
Source: prnewswire.com
Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology to Solve Therapeutics to Develop and Commercialize Novel Antibody-Drug Conjugates.
/PRNewswire/ -- Nerviano Medical Sciences S.r.l. (NMS), a clinical-stage biotechnology company member of NMS Group S.p.A. (NMS group), the largest cancer...
Source: prnewswire.com
Solve Therapeutics launches to tackle cancer
Solve Therapeutics, an oncology-focused biopharma company, has launched with the mission of developing novel antibody-based therapies.
Source: labiotech.eu